MedPath

Ohio State University Comprehensive Cancer Center

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.cancer.osu.edu

HPV Self-Test Intervention in Ohio Appalachia

Not Applicable
Completed
Conditions
Cervical Carcinoma
Human Papillomavirus Infection
Interventions
Procedure: Disease Screening
Other: Educational Intervention
Other: Informational Intervention
Other: Laboratory Biomarker Analysis
Other: Survey Administration
First Posted Date
2015-06-02
Last Posted Date
2018-02-08
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
103
Registration Number
NCT02460237
Locations
🇺🇸

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acute Leukemia Undergoing Chemotherapy

Not Applicable
Completed
Conditions
Anxiety
Nausea
Dyspnea
Pain
Acute Leukemia
Anorexia
Depression
Insomnia
Interventions
Procedure: Aromatherapy and Essential Oils
Other: Placebo
Other: Questionnaire Administration
First Posted Date
2015-05-15
Last Posted Date
2019-04-05
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
48
Registration Number
NCT02445378
Locations
🇺🇸

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Effect of Black Raspberry Phytochemicals on Oral Microbiome in Current Smokers and Non-smokers

Not Applicable
Completed
Conditions
Healthy Subject
Tobacco Use Disorder
Interventions
Other: Laboratory Biomarker Analysis
Other: Placebo
Dietary Supplement: Phytochemical
Other: Screening Questionnaire Administration
First Posted Date
2015-05-08
Last Posted Date
2022-10-05
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
148
Registration Number
NCT02439255
Locations
🇺🇸

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Typhoid Vaccine in Testing Response to Immune Stress in Patients With Stage I-IIIA Breast Cancer

Early Phase 1
Completed
Conditions
Cognitive Side Effects of Cancer Therapy
Recurrent Breast Carcinoma
Stage IA Breast Cancer
Stage IB Breast Cancer
Depression
Stage IIA Breast Cancer
Stage IIB Breast Cancer
Stage IIIA Breast Cancer
Interventions
Biological: typhoid vaccine
Other: Placebo
First Posted Date
2015-04-14
Last Posted Date
2024-07-24
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
172
Registration Number
NCT02415387
Locations
🇺🇸

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Wexner Medical Center, Columbus, Ohio, United States

Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients with Breast Cancer

Not Applicable
Recruiting
Conditions
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IA Breast Cancer
Stage IB Breast Cancer
Stage IIIC Breast Cancer
Stage IIB Breast Cancer
Stage 0 Breast Cancer
Stage IIA Breast Cancer
Interventions
Behavioral: Telephone-Based Intervention
Other: Survey Administration
Other: Laboratory Biomarker Analysis
First Posted Date
2015-03-26
Last Posted Date
2025-03-20
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
314
Registration Number
NCT02400060
Locations
🇺🇸

Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, United States

🇺🇸

Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States

🇺🇸

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

and more 1 locations

iPad Use in Reducing Anxiety and Depression in Patients Undergoing Bone Marrow Transplant

Not Applicable
Terminated
Conditions
Depression
Malignant Neoplasm
Anxiety
Interventions
Other: Computer-Assisted Intervention
Other: Questionnaire Administration
First Posted Date
2015-03-04
Last Posted Date
2020-06-24
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
6
Registration Number
NCT02378012
Locations
🇺🇸

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Prostate Biomarkers in Men Consuming Tomato Products

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
Other: Commercially-available tomato food product
First Posted Date
2014-11-17
Last Posted Date
2014-11-17
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
33
Registration Number
NCT02292524
Locations
🇺🇸

The Ohio State University Comprehensive Cancer Center/ We, Columbus, Ohio, United States

Harvesting Health Program in Improving Diet and Physical Activity Level in Cancer Survivors

Not Applicable
Completed
Conditions
Cancer Survivor
Interventions
Other: education
Other: nutrition intervention
Behavioral: exercise intervention
Other: questionnaire administration
Other: laboratory biomarker analysis
Other: quality-of-life assessment
First Posted Date
2014-10-20
Last Posted Date
2019-08-30
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
35
Registration Number
NCT02268188
Locations
🇺🇸

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery

Phase 2
Active, not recruiting
Conditions
Recurrent Non-small Cell Lung Cancer
Stage IIA Non-small Cell Lung Cancer
Stage IIIA Non-small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer
Stage IIB Non-small Cell Lung Cancer
Interventions
Radiation: hypofractionated radiation therapy
Radiation: 3-dimensional conformal radiation therapy
Other: laboratory biomarker analysis
First Posted Date
2014-10-13
Last Posted Date
2024-08-23
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
21
Registration Number
NCT02262325
Locations
🇺🇸

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation Therapy

Active, not recruiting
Conditions
Adult Brain Tumor
Lung Cancer
Radiation Toxicity
Interventions
Other: laboratory biomarker analysis
First Posted Date
2014-10-08
Last Posted Date
2025-03-24
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
273
Registration Number
NCT02259218
Locations
🇺🇸

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath